We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

New NIH Recovery Act Opportunity Seeks to Fund High Impact, Large-Scale, Accelerated Research

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute
The National Institutes of Health highlighted a new funding opportunity under the Recovery Act that will support approximately $200 million in large-scale research projects that have a high likelihood of enabling growth and investment in biomedical research and development, public health and health care delivery.

The purpose of this new program, the Research and Research Infrastructure "Grand Opportunities" (GO), is to support high impact ideas that lend themselves to short-term funding and may lay the foundation for new fields of scientific inquiry.

"With this new program, we will support large biomedical and biobehavioral research endeavors that will benefit from a significant two-year jumpstart in funds and are ready for immediate implementation," said Acting NIH Director Raynard S. Kington, M.D., Ph.D. "The goals are to fund high impact research that will lead to growth and investment in these fields and stimulate the economy in the process."

In responding to this opportunity, grant applicants may propose to address either a specific research question or the creation of a unique infrastructure/resource designed to accelerate scientific progress in the future. The GO grants will support large-scale research projects that accelerate critical breakthroughs, early and applied research on cutting edge technologies, and new approaches to improve the synergy and interactions among multi and interdisciplinary research teams.

Each participating NIH Institute has indicated their priorities for the GO grants. An example of the type of project that could be funded under this program is the identification and validation of biomarkers in human genetics and biology that indicate the risk for disease or that could serve as a marker of disease progression and/or responsiveness to treatment.

Validation of biomarkers could dramatically improve the detection, prevention, and treatment of disease. Another priority is research on information technology that will enable physicians to share radiological images across health care institutions, which could result in reduced health care costs, as well as improved accuracy for medical decision-making.